Announcement on Receiving the Clinical Trial Approval Notice for Qingshen Tongluo Granules

About this update from Jiangsu Kanion Pharmaceutical Co. Ltd. Class A

Announcement on Receiving the Clinical Trial Approval Notice for Qingshen Tongluo Granules The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Kanion Pharmaceutical Co. Ltd. Class A